Survival analysis further substantiated the clinical relevance of these findings, showing that high levels of Nur77 and H3K18La were associated with shorter OS in SCLC patients treated with immunotherapy (Figure 5h,i). Here, NR4A1 is linked to small cell lung carcinoma.